Bellevue Group Ag Arvinas, Inc. Transaction History

Bellevue Group Ag

  • $5.93 Billion
  • Q3 2024

A detailed history of Bellevue Group Ag transactions in Arvinas, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 2,386,600 shares of ARVN stock, worth $61.4 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
2,386,600
Previous 2,390,800 0.18%
Holding current value
$61.4 Million
Previous $63.6 Million 7.64%
% of portfolio
0.99%
Previous 1.06%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$23.66 - $32.73 $99,372 - $137,466
-4,200 Reduced 0.18%
2,386,600 $58.8 Million
Q1 2024

May 15, 2024
SELL
$36.38 - $52.31 $4.25 Million - $6.12 Million
-116,931 Reduced 4.66%
2,390,800 $98.7 Million
Q4 2023

Feb 14, 2024
BUY
$14.19 - $42.33 $5.43 Million - $16.2 Million
382,531 Added 18.0%
2,507,731 $103 Million
Q3 2023

Nov 14, 2023
SELL
$19.64 - $28.21 $35,352 - $50,778
-1,800 Reduced 0.08%
2,125,200 $41.7 Million
Q1 2023

May 15, 2023
SELL
$26.15 - $37.26 $612,223 - $872,331
-23,412 Reduced 1.09%
2,127,000 $58.1 Million
Q4 2022

Feb 14, 2023
SELL
$32.47 - $57.24 $1.31 Million - $2.31 Million
-40,350 Reduced 1.84%
2,150,412 $73.6 Million
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $2.78 Million - $3.86 Million
66,486 Added 3.13%
2,190,762 $97.5 Million
Q2 2022

Aug 11, 2022
SELL
$36.01 - $74.24 $1.98 Million - $4.08 Million
-54,977 Reduced 2.52%
2,124,276 $89.4 Million
Q1 2022

May 13, 2022
SELL
$60.27 - $81.57 $3.26 Million - $4.42 Million
-54,150 Reduced 2.42%
2,179,253 $147 Million
Q4 2021

Feb 10, 2022
SELL
$65.85 - $96.21 $526,800 - $769,680
-8,000 Reduced 0.36%
2,233,403 $183 Million
Q3 2021

Nov 12, 2021
BUY
$73.2 - $107.87 $292,800 - $431,480
4,000 Added 0.18%
2,241,403 $184 Million
Q2 2021

Aug 12, 2021
BUY
$60.45 - $84.26 $10 Million - $14 Million
165,900 Added 8.01%
2,237,403 $172 Million
Q1 2021

May 12, 2021
SELL
$58.19 - $91.37 $6.98 Million - $11 Million
-120,000 Reduced 5.48%
2,071,503 $137 Million
Q4 2020

Feb 16, 2021
BUY
$20.19 - $84.93 $11.1 Million - $46.7 Million
550,000 Added 33.51%
2,191,503 $186 Million
Q3 2020

Nov 16, 2020
BUY
$22.99 - $36.34 $1.37 Million - $2.17 Million
59,800 Added 3.78%
1,641,503 $38.8 Million
Q2 2020

Aug 13, 2020
BUY
$29.88 - $56.74 $9.33 Million - $17.7 Million
312,400 Added 24.61%
1,581,703 $53.1 Million
Q1 2020

May 14, 2020
BUY
$33.0 - $54.5 $904,200 - $1.49 Million
27,400 Added 2.21%
1,269,303 $51.2 Million
Q4 2019

Feb 14, 2020
BUY
$15.39 - $44.38 $6.7 Million - $19.3 Million
435,500 Added 54.01%
1,241,903 $51 Million
Q3 2019

Nov 14, 2019
BUY
$21.55 - $27.61 $17.4 Million - $22.3 Million
806,403 New
806,403 $17.4 Million

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.37B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email